Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 2—February 2012

Declining Guillain-Barré Syndrome after Campylobacteriosis Control, New Zealand, 1988–2010

Michael G. BakerComments to Author , Amanda Kvalsvig, Jane Zhang, Rob Lake, Ann Sears, and Nick Wilson
Author affiliations: University of Otago, Wellington, New Zealand (M.G. Baker, A. Kvalsvig, J. Zhang, A. Sears, N. Wilson); Institute of Environmental Science and Research, Christchurch, New Zealand (R. Lake)

Main Article

Table 5

Comparsion of ages of patients with campylobacteriosis and GBS, New Zealand, July 1995–December 2008*

Calculation A. Patients with campylobacteriosis
B. Patients hospitalized for campylobacteriosis
C. Patients hospitalized for GBS
D. Patients hospitalized for GBS and campylobacteriosis‡
Age, y Age, y p value for age compared with A§ Age, y p value for age compared with B§ Age, y p value for age compared with C§
Mean 33.7 43.7 <0.0001 48.8 <0.0001 50.3 0.7063
Median 31 41 <0.0001 52.5 <0.0001 54 0.7280

*GBS, Guillain-Barré syndrome.
‡Includes subsequent and concurrent hospitalizations (campylobacteriosis and GBS diagnoses at time of hospital discharge).
§Means compared with Student t-test medians compared with median 2-sample test.

Main Article

Page created: January 26, 2012
Page updated: January 26, 2012
Page reviewed: January 26, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.